<!DOCTYPE html>
<html lang="en-US">
  <head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    <meta name="author" content="map[]" />
    <meta name="description" content="Describe your website">
    <link rel="shortcut icon" type="image/x-icon" href="../img/favicon.ico">
    <title></title>
    <meta name="generator" content="Hugo 0.20.7" />
    <link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.7/css/bootstrap.min.css" integrity="sha384-BVYiiSIFeK1dGmJRAkycuHAHRg32OmUcww7on3RYdg4Va+PmSTsz/K68vbdEjh4u" crossorigin="anonymous">
    <link rel="stylesheet" type="text/css" href="../css/main.css" />
    <link rel="stylesheet" type="text/css" href="https://maxcdn.bootstrapcdn.com/font-awesome/4.6.3/css/font-awesome.min.css" />
    <link rel="stylesheet" href="../academicons/css/academicons.css"/>
    <link rel="stylesheet" type="text/css" href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:200,400,200bold,400old" />

    

<script>
(function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
(i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
})(window,document,'script','https://www.google-analytics.com/analytics.js','ga');

ga('create', 'UA-49177216-1', 'auto');
ga('send', 'pageview');
</script>

  </head>

  <body>
    <div id="wrap">


      <nav class="navbar navbar-default">
  <div class="container">
    <div class="navbar-header">
      <a class="navbar-brand" href="../"><i class="fa fa-home"></i></a>
    </div>
    <div id="navbar">
      <ul class="nav navbar-nav navbar-right">


        <li><a href="https://www.gerkelab.com/">LAB</a></li>

        <li><a href="../publications/">PUBLICATIONS</a></li>

        <li><a href="../cv/">CV</a></li>


      </ul>
    </div>
  </div>
</nav>


      <div class="container">
        
        <div class="blog-title">
          <h4>Peer-reviewed publications</h4> <h6>Last update: November 11, 2018</h6>
        </div>
        <div class="panel panel-default">
          <div class="panel-body">
            <div class="blogpost">
              <ol style="list-style-type: decimal">
<li><p><strong>Gerke TA</strong>, Randles RH. A method for resolving ties in asymptotic relative efficiency. Stat Probabil Lett 2010; 80:1065–1069.</p></li>
<li><p>Kachouie NN, <strong>Gerke TA</strong>, Huybers P, Schwartzman A. Nonparametric regression for estimation of spatiotemporal mountain glacier retreat from satellite images. IEEE Trans Geosci Remote Sens 2014; 53(3): 1135–1149.</p></li>
<li><p>Shui IM, Lindström S, Berndt SI, Campa D, <strong>Gerke TA</strong>, Penney KL, Albanes D, Berg C, Bueno-de-Mesquita HB, Chanock S, Crawford ED, Diver WR, Gapstur SM, Gaziano JM, Hoover R, Johansson M, Ma J, Navarro C, Overvad K, Siddiq A, Stampfer MJ, Stevens VL, Travis R, Trichopoulos D, Vineis P, Mucci LA, Yaeger M, Giovannucci EL, Kraft P. Prostate Cancer (PCa) Risk Variants and Risk of Fatal PCa in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. Eur Urol 2014; 65(6): 1069–1075.</p></li>
<li><p>Bismar TA, Alshalalfa M, Petersen LF, Teng LH, <strong>Gerke TA</strong>, Bakkar A, Al-Mami A, Liu S, Dolph M, Mucci LA, Alhajj R. Interrogation of ERG gene rearrangements in prostate cancer identifies a prognostic 10-gene signature with relevant implication to patients’ clinical outcome. Brit J Urol Int 2014; 113(2): 309–319.</p></li>
<li><p>Penney KL, Sinnott JA, Tyekucheva S, <strong>Gerke TA</strong>, Shui IM, Kraft P, Sesso HD, Freedman M, Loda MF, Mucci LA, Stampfer MJ. Association of prostate cancer risk variants with gene expression in normal and tumor tissue. Cancer Epidemiol Biomarkers Prev 2015; 24(1): 255–260</p></li>
<li><p>Shui IM, Mondul AM, Lindström S, Tsilidis KK, Travis RC, <strong>Gerke TA</strong>, Albanes D, Black A, Berg CD, Bueno-de-Mesquita HB, Gapstur SM, Haiman C, Henderson B, Hoover R, Hunter DJ, Johansson M, Key TJ, Khaw K, Marchand L, Ma J, McCullough ML, Siddiq A, Stampfer M, Stram DO, Stevens VL, Trichopoulos D, Tumino R, Willett W, Ziegler RG, Kühn T, Barricarte A, Tjønneland A, Mucci LA, Giovannucci E, Kraft P. Circulating vitamin D, vitamin D-related genetic variation, and risk of fatal prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. Cancer 2015; 121(12): 1949–1956.</p></li>
<li><p>Sinnott JA, Rider JR, Carlsson J, <strong>Gerke TA</strong>, Tyekucheva S, Penney K, Sesso HD, Loda M, Parmigiani G, Fall K, Stampfer MJ, Mucci LA, Pawitan Y, Andersson S, Andrén O. Molecular Differences in Transition Zone and Peripheral Zone Prostate Tumors. Carcinogenesis 2015; 36(6): 632–638.</p></li>
<li><p>Rider JR, Fiorentino M, Kelly R, <strong>Gerke TA</strong>, Jordahl K, Sinnott JA, Giovannucci EL, Loda MF, Mucci LA, Finn S. Tumor expression of Adiponectin Receptor 2 and lethal prostate cancer. Carcinogenesis 2015; 36(6): 639–647.</p></li>
<li><p>Terry RS, <strong>Gerke TA</strong>, Mason JB, Sorenson MD, Joseph JP, Dahm P, Su L. Postoperative rhabdomyolysis following robotic renal and adrenal surgery: a cautionary tale of compounding risk factors. J Robotic Surg 2015; 9(3): 195–200.</p></li>
<li><p>Martin NE, <strong>Gerke TA</strong>, Sinnott JA, Stack EC, Andrén O, Andersson S, Johansson J, Fiorentino M, Finn S, Fedele G, Stampfer MJ, Kantoff PW, Mucci LA, Loda MF. Measuring PI3K activation: Clinicopathologic, immunohistochemical, and RNA expression analysis in prostate cancer. Mol Cancer Res 2015; 13(10): 1431–1440.</p></li>
<li><p><strong>Gerke TA</strong><sup>*</sup>, Martin NE<sup>*</sup>, Ding Z, Nuttall E, Stack EC, Giovannucci EL, Lis RT, Stampfer MJ, Kantoff PW, Parmigiani G, Loda MF, Mucci LA. Evaluation of the time-dependent prognostic value of a molecular signature of lethal outcome in prostate cancer. Prostate 2015; 75(16): 1926–1933.</p></li>
<li><p>Ahearn T, Pettersson A, Ebot EM, <strong>Gerke TA</strong>, Graff R, Morais CL, Hicks J, Wilson KM, Rider JR, Sesso HD, Fiorentino M, Flavin R, Finn S, Giovannucci EL, Loda M, Stampfer MJ, De Marzo AM, Mucci LA, Lotan TL. A prospective investigation of PTEN loss and ERG expression in lethal prostate cancer. JNCI 2015; 108(2): pii djv346.</p></li>
<li><p>Conboy L, <strong>Gerke TA</strong>, Hsu KY, St John M, Goldstein M, Schnyer R. The effectiveness of individualized acupuncture protocols in the treatment of Gulf War Illness: A pragmatic randomized clinical trial. PLoS One 2016; 11(3): e0149161.</p></li>
<li><p>Lu D, Sinnott JA, Valdimarsdóttir U, Fang F, <strong>Gerke TA</strong>, Tyekucheva S, Fiorentino M, Lambe M, Sesso HD, Sweeney CJ, Wilson KM, Giovannucci EL, Loda M, Mucci LA, Fall K. Stress-related signaling pathways in lethal and non-lethal prostate cancer. Clin Cancer Res 2016; 22(3): 765–772.</p></li>
<li><p>Stopsack KH, <strong>Gerke TA</strong>, Sinnott JA, Penney KL, Tyekucheva S, Sesso HD, Andersson S, Andrén O, Cerhan JR, Giovannucci EL, Mucci LA, Rider JR. Cholesterol metabolism and lethal prostate cancer. Cancer Res 2016; 76(16): 4785–4790.</p></li>
<li><p>Preston MA, Batista JL, Carlsson SV, <strong>Gerke TA</strong>, Sjoberg DD, Dahl DM, Sesso H, Feldman AS, Gann PH, Vickers AJ, Mucci LA. Baseline prostate-specific antigen (PSA) levels in midlife predict lethal prostate cancer. J Clin Oncol 2016; 34(23): 2705–2711.</p></li>
<li><p>Moore II RA, <strong>Gerke TA</strong>, Bourgoine D, Eamranond PP. Transition coach program implementation associated with thirty-day readmission rates in a community hospital setting. Arch Community Med Public Health 2016; 2(1): 022-026. DOI: 10.17352/2455-5479.000012.</p></li>
<li><p>Waniga HM, <strong>Gerke TA</strong>, Shoemaker A, Bourgoine D, Eamranond P. The impact of revised discharge instructions on patient satisfaction. J Patient Experience 2016; 3(3): 64–68.</p></li>
<li><p>Kelly RS, Sinnott JA, Rider JR, Ebot E, <strong>Gerke TA</strong>, Bowden M, Pettersson A, Loda M, Sesso H, Kantoff PW, Martin NE, Giovannucci EL, Tyekucheva S, Vander Heiden M, Mucci LA. The role of tumor metabolism as a driver of prostate cancer progression and lethal disease: Results from a nested case-control study. Cancer Metab 2016; 4(22): DOI 10.1186/s40170-016-0161-9.</p></li>
<li><p>Sinnott JA, Peisch S, Tyekucheva S, <strong>Gerke TA</strong>, Lis RT, Rider JR, Fiorentino M, Stampfer MJ, Mucci LA, Loda M, Penney KL. Prognostic utility of a new mRNA expression signature of Gleason score. Clin Cancer Res 2017; 23(1): 81-87.</p></li>
<li><p>Fankhauser CD, Mucci LA, <strong>Gerke TA</strong>. Re: New prostate cancer grading system predicts long-term survival following surgery for Gleason score 8-10 prostate cancer. Eur Urol 2017; 72(1): e9-e10.</p></li>
<li><p>Pettersson A<sup>*</sup>, <strong>Gerke TA</strong><sup>*</sup>, Fall K, Pawitan Y, Holmberg L, Giovannucci EL, Kantoff PW, Adami H, Rider JR, Mucci LA. The ABC model of prostate cancer: a conceptual framework for the design and interpretation of prognostic studies. Cancer 2017; 123(9): 1490-1496.</p></li>
<li><p>Zareba P, Flavin R, Isikbay M, Rider JR, <strong>Gerke TA</strong>, Finn S, Pettersson A, Giunchi F, Unger RH, Andersson SO, Giovannucci EL, Andrén O, Fall K, Fiorentino M, Mucci LA. Perineural invasion and risk of lethal prostate cancer. Cancer Epidemiol Biomarkers Prev 2017; 26(5): 719-726.</p></li>
<li><p>Chen Z, <strong>Gerke TA</strong>, Bird V, Prosperi M. Trends in gene expression profiling for prostate cancer risk assessment: a systematic review. Biomed Hub 2017; 2:472146.</p></li>
<li><p>Ebot E, <strong>Gerke TA</strong>, Labbé D, Sinnott J, Zadra G, Rider J, Tyekucheva S, Wilson K, Kelly R, Shui I, Loda M, Kantoff P, Finn S, Vander Heiden M, Giovannucci E, Brown M, Mucci LA. Gene expression profiling of prostate tissue identifies chromatin regulation as a potential link between obesity and lethal prostate cancer.  Cancer 2017; 123(21): 4130-4138.</p></li>
<li><p>Mucci LA, Pernar CH, Peisch S, <strong>Gerke TA</strong>, Wilson KM. Prostate cancer incidence as an iceberg. Eur J Epidemiol 2017; 32(6): 477-479.</p></li>
<li><p>Stopsack KH, <strong>Gerke TA</strong>, Andrén O, Andersson S, Giovannucci EL, Mucci LA, Rider JR. Cholesterol uptake and regulation in high-grade and lethal prostate cancers. Carcinogenesis 2017; 38(8): 806-811.</p></li>
<li><p>Wang K, Chen X, Bird VY, <strong>Gerke TA</strong>, Manini TM, Prosperi M. Association between age-related reductions in testosterone and risk of prostate cancer &mdash; an analysis of patients' data with prostatic diseases. Int J Cancer 2017; 141(9): 1783-1793.</p></li>
<li><p>Li D, Mai V, <strong>Gerke TA</strong>, Pinney SM, Yaghjyan L. Interactions of family history of breast cancer with radiotherapy in relation to the risk of breast cancer recurrence. J Breast Cancer 2017; 20(4): 333--339.</p></li>
<li><p>Pettersson A<sup>*</sup>, <strong>Gerke TA<sup>*</sup></strong>, Penney KL, Lis R, Stack EC, Pértega-Gomes N, Zadra G, Tyekucheva S, Giovannucci EL, Mucci LA, Loda M. MYC overexpression at the protein and mRNA level and cancer outcomes among men treated with radical prostatectomy for prostate cancer. Cancer Epidemiol Biomarkers Prev 2018; 27(2): 201-207. PMID: 29141848 PMCID: PMC5831163.</p></li>
<li><p>Graff RE, Ahearn TU, Pettersson A, Ebot EM, <strong>Gerke TA</strong>, Penney KL, Wilson KM, Markt S, Pernar CH, Gonzalez-Feliciano AG, Song M, Lis R, Schmidt DR, Vander Heiden MG, Fiorentino M, Giovannucci EL, Loda M, Mucci LA. Height, obesity, and the risk of TMPRSS2:ERG-defined prostate cancer. Cancer Epidemiol Biomarkers Prev 2018; 27(2): 193-200. PMID: 29167279 PMCID: PMC5809280.</p></li>
<li><p>Jones AA, <strong>Gerke TA</strong>, Striley CW, Whitehead N, Osborne V, Cottler LB. One step at a time: A latent transitional analysis on changes in substance use, exposure to violence, and HIV/AIDS risk behaviors among female offenders. Am J Crim Just 2017; In press: DOI:10.1007/s12103-017-9419-1.</p></li>
<li><p>Jones AA, O'Leary CC, Striley CW, <strong>Gerke TA</strong>, Striley CW, Crecelius R, Sullivan J, Cottler LB. Substance use, victimization, HIV/AIDS risk, and recidivism among females in a therapeutic justice program. J Subst Use 2018; In press:\\DOI:10.1080/14659891.2018.1436604.</p></li>
<li><p>Williams V, Awasthi S, Fink A, Pow-Sang J, Park J, <strong>Gerke TA</strong>, Yamoah K. African American Men and prostate cancer specific mortality: A competing risk analysis of a large institutional cohort, 1989-2015. Cancer Med 2018; In press. </p></li>
<li><p>Komura K, Yoshikawa Y, Shimamura T, Chakraborty G, <strong>Gerke TA</strong>, Hinohara K, Chadalavada K, Jeong SH,  Armenia J, Du S, Mazzu YZ, Taniguchi K, Ibuki N, Meyer CA, Nanjangud G, Inamoto T, Lee GM, Mucci L, Azuma H, Sweeney CJ, Kantoff P. Synthetic lethality by ATR inhibition in aggressive prostate cancer deficient in male specific histone demethylase KDM5D. J Clin Investig 2018; In press. </p></li>
<li><p>Peeri NC<sup>*</sup>, Creed J<sup>*</sup>, Anic GM, Olson JJ, LaRocca RV, Chowdhary SJ, Brockman JD, <strong>Gerke TA</strong>, Nabors LB, Egan KM. Toenail selenium, genetic variation in selenoenzymes and risk and outcome in glioma. Cancer Epidemiol 2018; In press.</p></li>
<li><p>Rounbehler RJ, Berglund AE, <strong>Gerke TA</strong>, Takhar MM, Awasthi S, Li W, Davicioni E, Erho NG, Ross AE, Schaeffer EM, Klein EA, Karnes RJ, Jenkins RB, Cleveland JL, Park JY, Yamoah K. Tristetraprolin is a prognostic biomarker for poor outcomes among patients with low-grade prostate cancer. Cancer Epidemiol Biomarkers Prev 2018; In press.</p></li>
<li><p>Barber L, <strong>Gerke TA</strong>, Markt S, Peisch S, Wilson K, Ahearn T, Giovannucci E, Parmigiani G, Mucci L. Family history of breast or prostate cancer and prostate cancer risk. Clin Cancer Res 2018; In press.</p></li>
<li><p>Stopsack KH, Ebot EM, Downer MK, <strong>Gerke TA</strong>, Rider JR, Kantoff PW, Mucci LA. Regular aspirin use and gene expression profiles in prostate cancer patients. 	Cancer Causes Control 2018; In press.</p></li>
<li><p>Ahearn TU<sup>*</sup>, Peisch S<sup>*</sup>, Pettersson A, Ebot EM, Zhou K, Graff RE, Sinnott JA, Fazli L, Judson GJ, Bismar TA, Rider JR, <strong>Gerke TA</strong>, Chan JM, Fiorentino M, Flavin R, Sesso HD, Finn S, Giovannucci EL, Gleave M, Loda M, Li Z, Pollak M<sup>**</sup>, Mucci LA<sup>**</sup>. Expression of IGF/insulin receptor in prostate cancer tissue and progression to lethal disease. Carcinogenesis 2018; In press. </p></li>
<li><p>Preston MA<sup>*</sup>, <strong>Gerke TA</strong><sup>*</sup>}, Carlsson SV, Signorello L, Sjoberg DD, Markt SC, Kibel AS, Trinh Q, Steinwandel M, Blot W, Vickers AJ, Lilja H, Mucci LA<sup>**</sup>, Wilson KM<sup>**</sup>. Baseline prostate-specific antigen level in midlife and aggressive prostate cancer in black men. Eur Urol 2018; In press.</p></li>
<li><p>Yamoah K, Berglund A, Rounbehler R, <strong>Gerke TA</strong>, Awasthi S, Cheng C, Takhar M, Alshalalfa M, Erho N, Klein E, Freedland S, Ross A, Schaeffer E, Trock B, Den R, Cleveland J, Park J, Dhillon J. Distinct transcriptional repertoire of the androgen receptor in ETS fusion-negative prostate cancer. Prostate Cancer Prostatic Dis 2018; In press.</p></li>
<li><p><strong>Gerke TA</strong>, Beltran H, Wang X, Lee G, Sboner A, Karnes RJ, Klein EA, Davicioni E, Yousefi K, Ross AE, Börnigen D, Huttenhower C, Mucci LA, Trock BJ, Sweeney CJ. Low tristetraprolin expression is associated with lethal prostate cancer. Cancer Epidemiol Biomarkers Prev 2018; In press.</p></li>
<li><p>Awasthi A, <strong>Gerke TA</strong>, Park JY, Asamoah FA, Williams VL, Fink AK, Balkrishnan R, Lee D, Malkowicz SB, Lal P, Dhillon J, Pow-Sang JM, Rebbeck TR, Yamoah K. Optimizing time-to-treatment to achieve durable biochemical disease control after surgery in prostate cancer - A multi-institutional cohort study. Cancer Epidemiol Biomarkers Prev 2018; In press.</p></li>
</ol>


            </div>
          </div>


        </div>
      </div>

      <div class="container">
        <div class="blog-title">
          <h4>Preprints</h4>
        </div>
        <div class="panel panel-default">
          <div class="panel-body">
            <div class="blogpost">
              <ol style="list-style-type: decimal">
                <li><p><strong>Gerke TA</strong>, Tyekucheva S, Mucci LA, Parmigiani G. Logistic push: a regression framework for partial AUC optimization. arXiv:1606.06562 [stat.AP]. <a href=https://arxiv.org/abs/1606.06562>https://arxiv.org/abs/1606.06562</a>.</p></li>
                <li><p>Creed JH, Monteiro AN, <strong>Gerke TA</strong>. epiTAD: a web application for visualizing high throughput chromosome conformation capture data in the context of genetic epidemiology. bioRxiv 243840. <a href=https://www.biorxiv.org/content/early/2018/01/05/243840>https://www.biorxiv.org/content/early/2018/01/05/243840</a></p></li>
              </ol>
            </div>
          </div>
        </div>
      </div>

      <div class="container">
        <div class="blog-title">
          <h4>Conference papers</h4>
        </div>
        <div class="panel panel-default">
          <div class="panel-body">
            <div class="blogpost">
              <ol style="list-style-type: decimal">
                <li><p>Tradigo G, Vaccac R, Manini T, Bird V, <strong>Gerke T</strong>, Veltri P, Prosperi M. A new approach to disentangle genetic and epigenetic components on disease comorbidities: studying correlation between genotypic and phenotypic disease networks. Procedia Computer Science 2017; 110: 453--458. In: The 14th International Conference on Mobile Systems and Pervasive Computing (MobiSPC): 2017 Jul 24-26; Leuven, Belgium.</p></li>
                <li><p>Ren Y, Ay A, <strong>Gerke T</strong>, Kahveci T. Searching jointly correlated gene combinations. In: International Conference on Bioinformatics and Computational Biology (BICoB): 2018 Mar 19-21; Las Vegas, NV. Award: Best Paper. </p></li>
              </ol>
            </div>
          </div>
        </div>
      </div>

      <div class="container">
        <div class="blog-title">
          <h4>Software releases</h4>
        </div>
        <div class="panel panel-default">
          <div class="panel-body">
            <div class="blogpost">
              <ol style="list-style-type: decimal">
                <li><p>Barr CD, <strong>Gerke TA</strong>, Diez DM. voronoi: Methods and applications related to Voronoi tessellations. R package 2011; version 1.0.</p></li>
                <li><p>Creed JH, Monteiro AN, <strong>Gerke TA</strong>. epiTAD: A web application for visualizing high throughput chromosome conformation capture data in the context of genetic epidemiology. R Shiny Application 2018; latest development version <a href=https://github.com/tgerke/epiTAD>https://github.com/tgerke/epiTAD</a>.</p></li>
                <p><li>Creed JH, <strong>Gerke TA</strong>. ShinyDAG: A web application for building, analyzing, and visualizing directed acyclic graphs (DAGs). R Shiny Application 2018; latest development version <a href=https://github.com/gerkelab/ShinyDAG>https://github.com/gerkelab/ShinyDAG</a></li></p>
              </ol>
            </div>
          </div>
        </div>
      </div>

    </div>

  </body>
</html>
